Amplyx Pharmaceuticals Obtains $1,500,000 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=adf40e76-09a6-4112-95fe-2d626ad2da17
Date
8/19/2015
Company Name
Amplyx Pharmaceuticals
Mailing Address
3210 Merryfield Row San Diego, CA 92121 USA
Company Description
Amplyx Pharmaceuticals develops improved small molecule drugs.
Website
http://www.amplyx.com
Transaction Type
Debt
Transaction Amount
$1,500,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor
Undisclosed